TY - JOUR
T1 - Outcome of the Swedish Nationwide abdominal aortic aneurysm screening program
AU - Wanhainen, Anders
AU - Hultgren, Rebecka
AU - Linné, Anneli
AU - Holst, Jan
AU - Gottsäter, Anders
AU - Langenskiöld, Marcus
AU - Smidfelt, Kristian
AU - Björck, Martin
AU - Svensjö, Sverker
AU - Lyttkens, Linda
AU - Pihl, Ewa
AU - Wetterling, Tomas
AU - Kjellin, Per
AU - Eliasson, Ken
AU - Wellander, Erik
AU - Narbani, Azin
AU - Skagius, Elisabet
AU - Hollsten, Alexandra
AU - Welander, Martin
AU - Länne, Toste
AU - Fröst, Bibbi
AU - Korman, David
AU - Persson, Sven Erik
AU - Sigvant, Birgitta
AU - Troëng, Thomas
AU - Palm, Markus
AU - Ansgarius, Eva
AU - Gilgen, Nils Peter
AU - Sjöström, Christina
AU - Gidlund, Khatereh Djavani
AU - Danielsson, Peter
AU - Bersztel, Adam
AU - Jonasson, Tomas
PY - 2016/10/18
Y1 - 2016/10/18
N2 - Background: A general abdominal aortic aneurysm (AAA) screening program, targeting 65-year-old men, has gradually been introduced in Sweden since 2006 and reached nationwide coverage in 2015. The aim of this study was to determine the outcome of this program. Methods: Data on the number of invited and examined men, screening-detected AAAs, AAAs operated on, and surgical outcome were retrieved from all 21 Swedish counties for the years 2006 through 2014. AAA-specific mortality data were retrieved from the Swedish Cause of Death Registry. A linear regression analysis was used to estimate the effect on AAA-specific mortality among all men ≥65 years of age for the observed time period. The long-term effects were projected by using a validated Markov model. Results: Of 302 957 men aged 65 years invited, 84% attended. The prevalence of screening-detected AAA was 1.5%. After a mean of 4.5 years, 29% of patients with AAA had been operated on, with a 30-day mortality rate of 0.9% (1.3% after open repair and 0.3% after endovascular repair, P<0.001). The introduction of screening was associated with a significant reduction in AAA-specific mortality (mean, 4.0% per year of screening, P=0.020). The number needed to screen and the number needed to operate on to prevent 1 premature death were 667 and 1.5, respectively. With a total population of 9.5 million, the Swedish national AAA-screening program was predicted to annually prevent 90 premature deaths from AAA and to gain 577 quality-adjusted life-years. The incremental cost-efficiency ratio was estimated to be €7770 per quality-adjusted life-years. Conclusions: Screening 65-year-old men for AAA is an effective preventive health measure and is highly cost-effective in a contemporary setting. These findings confirm the results from earlier randomized controlled trials and model studies in a large population-based setting of the importance for future healthcare decision making.
AB - Background: A general abdominal aortic aneurysm (AAA) screening program, targeting 65-year-old men, has gradually been introduced in Sweden since 2006 and reached nationwide coverage in 2015. The aim of this study was to determine the outcome of this program. Methods: Data on the number of invited and examined men, screening-detected AAAs, AAAs operated on, and surgical outcome were retrieved from all 21 Swedish counties for the years 2006 through 2014. AAA-specific mortality data were retrieved from the Swedish Cause of Death Registry. A linear regression analysis was used to estimate the effect on AAA-specific mortality among all men ≥65 years of age for the observed time period. The long-term effects were projected by using a validated Markov model. Results: Of 302 957 men aged 65 years invited, 84% attended. The prevalence of screening-detected AAA was 1.5%. After a mean of 4.5 years, 29% of patients with AAA had been operated on, with a 30-day mortality rate of 0.9% (1.3% after open repair and 0.3% after endovascular repair, P<0.001). The introduction of screening was associated with a significant reduction in AAA-specific mortality (mean, 4.0% per year of screening, P=0.020). The number needed to screen and the number needed to operate on to prevent 1 premature death were 667 and 1.5, respectively. With a total population of 9.5 million, the Swedish national AAA-screening program was predicted to annually prevent 90 premature deaths from AAA and to gain 577 quality-adjusted life-years. The incremental cost-efficiency ratio was estimated to be €7770 per quality-adjusted life-years. Conclusions: Screening 65-year-old men for AAA is an effective preventive health measure and is highly cost-effective in a contemporary setting. These findings confirm the results from earlier randomized controlled trials and model studies in a large population-based setting of the importance for future healthcare decision making.
KW - aneurysm
KW - aorta
KW - cost-benefit analysis
KW - prevention and control
KW - screening
KW - ultrasonography
UR - http://www.scopus.com/inward/record.url?scp=84988640466&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.116.022305
DO - 10.1161/CIRCULATIONAHA.116.022305
M3 - Article
C2 - 27630132
AN - SCOPUS:84988640466
SN - 0009-7322
VL - 134
SP - 1141
EP - 1148
JO - Circulation
JF - Circulation
IS - 16
ER -